HARP

Harpoon Therapeutics (HARP)

Harpoon Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HARP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/12	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:55	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:51	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:49	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:46	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:42	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:40	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:37	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:36	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	22:32	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/11	21:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/03/09	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/28	21:37	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/28	21:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/22	22:32	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/22	22:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/08	21:00	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/02/07	06:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/30	06:52	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/30	06:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/11	05:07	PR Newswire (US)	Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/09	20:12	IH Market News	Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/09	07:20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/09	07:16	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/08	22:04	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/08	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/08	21:30	Business Wire	Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline	NASDAQ:HARP	Harpoon Therapeutics Inc
2024/01/06	07:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:HARP	Harpoon Therapeutics Inc
2023/12/26	21:30	GlobeNewswire Inc.	Harpoon Therapeutics Strengthens Leadership Team	NASDAQ:HARP	Harpoon Therapeutics Inc